| Heading: |
Cystic Fibrosis: Medical Treatments |
| Question ID: |
1812617 |
| UIN: |
59882 |
| House: |
Commons |
| Date tabled: |
2025-06-13 |
| Asking Member ID: |
5239 |
| Asking Member display name: |
Sarah Gibson
|
| Asking Member handle: |
|
| Asking Member Twitter reference: |
Sarah Gibson
|
| Member interest: |
false |
| Question text: |
To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure access to (a) cystic fibrosis transmembrane conductance regulator modulator therapies and (b) other cystic fibrosis treatments in rural parts of Wiltshire. |
| Is named day: |
false |
| Date of holding answer: |
|
| Date answered: |
2025-06-20 |
| Date answer corrected: |
|
| Is holding answer: |
false |
| Is correcting answer: |
false |
| Answering Member ID: |
4444 |
| Answering Member display name: |
Karin Smyth
|
| Answering Member handle: |
karinsmyth
|
| Answering Member Twitter reference: |
@karinsmyth
|
| Correcting Member ID: |
|
| Correcting Member display name: |
|
| Correcting Member handle: |
|
| Correcting Member Twitter reference: |
|
| Answer text: |
The National Institute for Health and Care Excellence (NICE) makes recommendations on whether licensed medicines should be routinely funded by the National Health Service in England based on a thorough assessment of the available evidence of clinical and ... |
| Original answer text: |
|
| Comparable answer text: |
|
| Answering body ID: |
17 |
| Answering body name: |
Department of Health and Social Care |
| Tweeted: |
true |